Klingenstein Fields & Co’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Sell
110,302
-1,113
-1% -$126K 0.45% 56
2025
Q4
$14M Sell
111,415
-824
-0.7% -$105K 0.52% 50
2025
Q3
$15M Sell
112,239
-3,481
-3% -$457K 0.57% 50
2025
Q2
$15.7M Sell
115,720
-14,537
-11% -$1.92M 0.62% 51
2025
Q1
$17.3M Buy
130,257
+155
+0.1% +$19.7K 0.73% 50
2024
Q4
$14.7M Buy
130,102
+2,701
+2% +$312K 0.59% 52
2024
Q3
$14.5M Buy
127,401
+171
+0.1% +$18.8K 0.58% 57
2024
Q2
$13.2M Buy
127,230
+134
+0.1% +$14.2K 0.55% 58
2024
Q1
$14.4M Sell
127,096
-2,159
-2% -$247K 0.6% 60
2023
Q4
$14.2M Sell
129,255
-2,415
-2% -$241K 0.63% 59
2023
Q3
$12.8M Sell
131,670
-162
-0.1% -$17K 0.62% 60
2023
Q2
$14.4M Sell
131,832
-2,080
-2% -$222K 0.66% 57
2023
Q1
$13.6M Buy
133,912
+1,357
+1% +$143K 0.68% 57
2022
Q4
$14.6M Buy
132,555
+156
+0.1% +$16.2K 0.76% 53
2022
Q3
$12.8M Buy
132,399
+1,703
+1% +$182K 0.7% 55
2022
Q2
$14.2M Sell
130,696
-1,053
-0.8% -$120K 0.74% 54
2022
Q1
$15.6M Buy
131,749
+338
+0.3% +$41.9K 0.67% 57
2021
Q4
$18.5M Sell
131,411
-1,590
-1% -$204K 0.74% 55
2021
Q3
$15.7M Sell
133,001
-2,971
-2% -$365K 0.67% 59
2021
Q2
$15.8M Sell
135,972
-3,982
-3% -$464K 0.65% 61
2021
Q1
$16.8M Buy
139,954
+258
+0.2% +$30.6K 0.76% 55
2020
Q4
$15.3M Buy
139,696
+1,532
+1% +$167K 0.69% 58
2020
Q3
$15M Sell
138,164
-1,131
-0.8% -$115K 0.75% 53
2020
Q2
$12.7M Buy
139,295
+9,793
+8% +$885K 0.7% 57
2020
Q1
$10.2M Buy
129,502
+710
+0.6% +$59.2K 0.67% 59
2019
Q4
$11.2M Sell
128,792
-1,079
-0.8% -$90.4K 0.56% 61
2019
Q3
$10.9M Sell
129,871
-2,574
-2% -$219K 0.57% 61
2019
Q2
$11.1M Buy
132,445
+6,940
+6% +$546K 0.58% 62
2019
Q1
$10M Buy
125,505
+28,221
+29% +$2.1M 0.54% 63
2018
Q4
$7.04M Buy
97,284
+7,780
+9% +$547K 0.3% 71
2018
Q3
$6.57M Buy
89,504
+55,148
+161% +$3.62M 0.24% 74
2018
Q2
$2.1M Hold
34,356
0.08% 99
2018
Q1
$2.06M Hold
34,356
0.08% 100
2017
Q4
$1.96M Sell
34,356
-870
-2% -$48.2K 0.07% 106
2017
Q3
$1.88M Sell
35,226
-480
-1% -$24.1K 0.07% 105
2017
Q2
$1.74M Sell
35,706
-361
-1% -$16.3K 0.07% 108
2017
Q1
$1.6M Buy
36,067
+1,121
+3% +$48.5K 0.07% 109
2016
Q4
$1.34M Sell
34,946
-5,423
-13% -$215K 0.06% 116
2016
Q3
$1.71M Sell
40,369
-643
-2% -$27.6K 0.08% 103
2016
Q2
$1.61M Sell
41,012
-13,165
-24% -$524K 0.08% 105
2016
Q1
$2.27M Sell
54,177
-10,535
-16% -$417K 0.11% 92
2015
Q4
$2.91M Sell
64,712
-1,476
-2% -$65.2K 0.14% 90
2015
Q3
$2.66M Sell
66,188
-4,090
-6% -$193K 0.13% 90
2015
Q2
$3.45M Sell
70,278
-2,050
-3% -$98.4K 0.15% 76
2015
Q1
$3.35M Sell
72,328
-1,500
-2% -$68.9K 0.15% 82
2014
Q4
$3.32M Sell
73,828
-2,450
-3% -$107K 0.15% 80
2014
Q3
$3.17M Buy
76,278
+7,307
+11% +$309K 0.14% 83
2014
Q2
$2.82M Sell
68,971
-5,029
-7% -$197K 0.12% 92
2014
Q1
$2.85M Sell
74,000
-418,189
-85% -$16.1M 0.13% 92
2013
Q4
$18.9M Sell
492,189
-68,606
-12% -$2.53M 0.67% 40
2013
Q3
$18.6M Sell
560,795
-90,998
-14% -$3.19M 0.73% 38
2013
Q2
$22.7M Buy
+651,793
New +$23.9M 0.81% 34

Other funds holding ABT

Klingenstein Fields & Co's ABT Position: Q1 2026 in Review

Klingenstein Fields & Co reduced its Abbott (ABT) stake by 1% in Q1 2026, selling an estimated $126K and leaving 110,302 shares worth $11.3M. The position accounts for 0.45% of the portfolio, ranked #56.

Klingenstein Fields & Co first reported a position in ABT in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.7M in Q2 2013. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Klingenstein Fields & Co held 110,302 shares of Abbott worth $11.3M as of Q1 2026.
  • Klingenstein Fields & Co sold 1,113 Abbott shares in Q1 2026, an estimated $126K.
  • Abbott made up 0.45% of Klingenstein Fields & Co's portfolio in Q1 2026, its #56 holding.
  • Klingenstein Fields & Co first reported a position in Abbott in Q2 2013 and has held it in 52 quarters since.
  • Klingenstein Fields & Co's Abbott position peaked at $22.7M in Q2 2013.
  • 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Klingenstein Fields & Co's 13F filing for Q1 2026, filed 13 May 2026.